A study by the well-known British Health Directorate showed on Saturday that the Pfizer and AstraZeneca vaccines are nearly effective against the coronavirus variant discovered in India compared to the type discovered in the United Kingdom.
The Public Health England (PHE) investigation was conducted between April 5 and May 16.
According to the study, Pfizer formula was 88% effective. Against accidental diseases caused by mutation detected in India two weeks after the second dose, 93% efficacy compared to detection in England.
Experts found that it is in good condition AstraZeneca / University of Oxford, vaccine was 60% effective Versus the variable discovered in India, Compared to 66% of the variant detected in the UK (Alternative Kent).
Both formulations were 33% effective against symptomatic disease related to the variant detected in India three weeks after the first dose, versus about 50% found in the UK (Kent variant).
According to the data, in the case of AstraZeneca vaccine, preparation takes longer to reach maximum efficacy.
British Health Secretary Matt Hancock said: “This new evidence is groundbreaking and shows how important the COVID-19 vaccination program is in protecting the people we love.”
The official added that there is now certainty that “more than 20 million people, more than one in three, enjoy great protection against this new alternative, and that this number is increasing by hundreds of thousands every day.”
PHE Immunization Officer Mary Ramsay, in turn, indicated that these results “give assurances that these two doses of vaccines provide high levels of protection against symptoms of the variable disease B1617.2”.
